Posterior Capsule Opacification

Posterior capsule opacification (PCO), sometimes colloquially called "secondary cataract," is the most common complication of modern cataract surgery, arising when lens epithelial cells (LECs) left behind after cataract extraction proliferate, migrate across the posterior capsule, and undergo changes that scatter light passing through the visual axis.¹ PCO is broadly divided into fibrotic PCO (wrinkling/opacification from epithelial-to-mesenchymal transition) and pearl-type (regenerative) PCO (clusters of swollen, translucent Elschnig pearls), which frequently co-occur, and by time course into acute-onset (weeks to months, now uncommon in adults) and late-onset (over years) forms.¹

PCO's clinical timeline has shifted with surgical technique and IOL design: acute-onset PCO has become relatively rare in adults because square-edge IOL optic designs create a physical barrier blocking residual LECs from migrating onto the central posterior capsule.¹ Despite this, PCO rates remain substantial by 5-10 years after surgery, apparently because LECs entrapped at the capsular-bag periphery (Soemmering's ring) can eventually escape and populate the visual axis.¹ Within hours of surgery, residual LECs express pro-inflammatory genes, initiating a wound-healing-like response, then proliferate and migrate to repopulate denuded capsule. Two overlapping processes drive visually significant late changes: fibrotic transformation of LECs into myofibroblast-like cells (TGF-β implicated as a key driver), and formation of Elschnig pearls.¹ In French national claims data, Nd:YAG capsulotomy was performed within two years of surgery in about a third of eventual patients, within one year in roughly 10%.² A Taiwanese case-control study found dry eye disease, glaucoma, uveitis, AMD, hyperlipidemia, and peptic ulcer disease each associated with increased odds of visually significant PCO.³

Patients present with gradual, painless blurring of vision, glare, or reduced contrast sensitivity recurring weeks to years after an initially successful cataract surgery. The presentation can be mistaken for a recurrence of cataract, though the native lens has already been removed — the opacity is entirely within the residual capsule and/or LEC proliferation.

Key differentials: residual refractive error or IOL decentration/dislocation, cystoid macular edema, corneal edema/endothelial decompensation, recurrent or progressive retinal/macular pathology unrelated to prior surgery, and uveitis with capsular inflammatory deposits.

Slit-lamp exam shows fibrotic wrinkling or an "orange-peel" appearance of the posterior capsule, and retroillumination reveals pearl-like clusters of opacified LECs (Elschnig pearls). Visual acuity and contrast sensitivity are reduced, often more pronounced with retroillumination or against a bright background than on standard acuity testing alone. A previously implanted, well-centered posterior chamber IOL is visible behind the opacified capsule.

Nd:YAG laser posterior capsulotomy is the standard, highly effective treatment: a brief outpatient laser procedure creates an opening in the central opacified posterior capsule to restore a clear visual axis. Because Nd:YAG capsulotomy carries a small risk of complications — transiently elevated IOP, retinal detachment, and cystoid macular edema — it is generally reserved for visually significant symptoms rather than performed prophylactically. Prevention begins at the time of cataract surgery: IOL optic materials and edge designs (particularly a sharp, square posterior optic edge) reduce the rate and delay the onset of PCO.¹ In a systematic review and meta-analysis of high myopic eyes, a capsular tension ring was evaluated for its effect on secondary outcomes including PCO/Nd:YAG rates, with findings described by the authors as modest and warranting cautious interpretation given the limited evidence base.⁴

• PCO rates have fallen sharply for acute-onset disease with modern square-edge IOL design, but late-onset PCO remains common by 5-10 years after surgery¹
• A "recurrent cataract" complaint years after uncomplicated cataract surgery should prompt evaluation for PCO on retroillumination, not just repeat refraction
• Comorbid ocular surface disease, glaucoma, AMD, and hyperlipidemia have each been associated with increased odds of visually significant PCO in population-based data³
• Common pitfall: assuming a return of blurred vision after cataract surgery always represents PCO without excluding other causes like cystoid macular edema or refractive shift
• Common pitfall: performing Nd:YAG capsulotomy reflexively for any visible capsular opacity rather than reserving it for visually significant symptoms
• Common pitfall: overlooking that "recurrent cataract" is a misleading lay description — the native lens has already been removed